U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07175909) titled 'Proteomics Analysis of Human Tears in the Diagnosis and Management of Dry Eye Disease' on Sept. 06.
Brief Summary: In this study, the initial tear proteome profiles in Dry Eye Disease (DED) patients, the safety and effectiveness of using an EC certificate DED treatment device in DED management, together with the associated global tear proteome changes, will be investigated.
Study Start Date: Jan. 01, 2021
Study Type: INTERVENTIONAL
Condition:
Dry Eye Disease (DED)
Dry Eye
Intervention:
DEVICE: The Rexon-Eye, an electrotherapy device utilizing Quantum Molecular Resonance (QMR) technology
The device has received EC certificati...